JP2022548112A5 - - Google Patents
Info
- Publication number
- JP2022548112A5 JP2022548112A5 JP2022516601A JP2022516601A JP2022548112A5 JP 2022548112 A5 JP2022548112 A5 JP 2022548112A5 JP 2022516601 A JP2022516601 A JP 2022516601A JP 2022516601 A JP2022516601 A JP 2022516601A JP 2022548112 A5 JP2022548112 A5 JP 2022548112A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- chain variable
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025005517A JP2025061323A (ja) | 2019-09-13 | 2025-01-15 | Ｃｄ３７１を標的にする抗原認識受容体およびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962900141P | 2019-09-13 | 2019-09-13 | |
| US62/900,141 | 2019-09-13 | ||
| US201962936951P | 2019-11-18 | 2019-11-18 | |
| US62/936,951 | 2019-11-18 | ||
| PCT/US2020/050386 WO2021050862A1 (en) | 2019-09-13 | 2020-09-11 | Antigen recognizing receptors targeting cd371 and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025005517A Division JP2025061323A (ja) | 2019-09-13 | 2025-01-15 | Ｃｄ３７１を標的にする抗原認識受容体およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022548112A JP2022548112A (ja) | 2022-11-16 |
| JP2022548112A5 true JP2022548112A5 (enExample) | 2023-09-06 |
| JP7776414B2 JP7776414B2 (ja) | 2025-11-26 |
Family
ID=74866657
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516601A Active JP7776414B2 (ja) | 2019-09-13 | 2020-09-11 | Ｃｄ３７１を標的にする抗原認識受容体およびその使用 |
| JP2025005517A Pending JP2025061323A (ja) | 2019-09-13 | 2025-01-15 | Ｃｄ３７１を標的にする抗原認識受容体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025005517A Pending JP2025061323A (ja) | 2019-09-13 | 2025-01-15 | Ｃｄ３７１を標的にする抗原認識受容体およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220213211A1 (enExample) |
| EP (1) | EP4028031A4 (enExample) |
| JP (2) | JP7776414B2 (enExample) |
| KR (1) | KR20220068232A (enExample) |
| CN (1) | CN114650830B (enExample) |
| AU (1) | AU2020346887A1 (enExample) |
| BR (1) | BR112022004594A2 (enExample) |
| CA (1) | CA3154389A1 (enExample) |
| IL (1) | IL291281A (enExample) |
| MX (1) | MX2022003047A (enExample) |
| WO (1) | WO2021050862A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021050857A1 (en) * | 2019-09-13 | 2021-03-18 | Memorial Sloan-Kettering Cancer Center | Anti-cd371 antibodies and uses thereof |
| EP4584283A1 (en) | 2022-11-14 | 2025-07-16 | Caribou Biosciences, Inc. | Anti-cll-1 chimeric antigen receptors, engineered cells and related methods |
| TW202442689A (zh) * | 2023-03-03 | 2024-11-01 | 美商亞森諾生物科學公司 | 靶向ｐｓｍａ及ｃａ９之系統 |
| WO2025193609A1 (en) | 2024-03-11 | 2025-09-18 | Caribou Biosciences, Inc. | Methods and compositions for cost-effective assessment of nucleic acid transcripts and isoforms in cells |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015188141A2 (en) * | 2014-06-06 | 2015-12-10 | Memorial Sloan-Kettering Cancer Ceneter | Mesothelin-targeted chimeric antigen receptors and uses thereof |
| BR112017000939A2 (pt) * | 2014-07-21 | 2017-11-14 | Novartis Ag | tratamento de câncer usando um receptor antigênico quimérico de cll-1 |
| WO2017023859A1 (en) * | 2015-07-31 | 2017-02-09 | Memorial Sloan-Kettering Cancer Center | Antigen-binding proteins targeting cd56 and uses thereof |
| SG10201912519VA (en) * | 2016-04-01 | 2020-02-27 | Kite Pharma Inc | Chimeric receptors and methods of use thereof |
| EP3344263A4 (en) * | 2016-08-04 | 2020-07-01 | Memorial Sloan-Kettering Cancer Center | CANCER ANTIGEN TARGETS AND USES THEREOF |
| US11905528B2 (en) * | 2017-10-12 | 2024-02-20 | Icell Gene Therapeutics Inc. | Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof |
| US11951129B2 (en) * | 2018-01-09 | 2024-04-09 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Compositions and methods for targeting CLEC12A-expressing cancers |
| US20190284288A1 (en) * | 2018-03-19 | 2019-09-19 | The Regents Of The University Of Michigan | Compositions and methods for t-cell and cytokine activation |
| IL279063B2 (en) * | 2018-05-31 | 2026-05-01 | Washington University St Louis | Chimeric antigen receptor T cells for cancer treatment |
-
2020
- 2020-09-11 AU AU2020346887A patent/AU2020346887A1/en active Pending
- 2020-09-11 CA CA3154389A patent/CA3154389A1/en active Pending
- 2020-09-11 EP EP20862173.0A patent/EP4028031A4/en active Pending
- 2020-09-11 KR KR1020227012165A patent/KR20220068232A/ko not_active Ceased
- 2020-09-11 WO PCT/US2020/050386 patent/WO2021050862A1/en not_active Ceased
- 2020-09-11 MX MX2022003047A patent/MX2022003047A/es unknown
- 2020-09-11 JP JP2022516601A patent/JP7776414B2/ja active Active
- 2020-09-11 CN CN202080078104.8A patent/CN114650830B/zh active Active
- 2020-09-11 BR BR112022004594A patent/BR112022004594A2/pt unknown
-
2022
- 2022-03-10 IL IL291281A patent/IL291281A/en unknown
- 2022-03-11 US US17/693,060 patent/US20220213211A1/en active Pending
-
2025
- 2025-01-15 JP JP2025005517A patent/JP2025061323A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12202870B2 (en) | Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereof | |
| US20250296970A1 (en) | Cd19-directed chimeric antigen receptors and uses thereof in immunotherapy | |
| US12059436B2 (en) | BCMA-CAR-T cells | |
| JP2022062001A (ja) | 抗ｐｄ－１抗体と突然変異ｉｌ－２とまたはｉｌ－１５とのイムノコンジュゲート | |
| JP2017537925A5 (enExample) | ||
| JP2021520805A (ja) | ４−１ＢＢＬを含むＨｅｒ２標的化抗原結合分子 | |
| US11725053B2 (en) | Chimeric antigen receptors comprising a human transferrin epitope sequence | |
| HRP20211978T1 (hr) | Kimerični antigenski receptori koji ciljaju receptor spojen na g-protein i njihove uporabe | |
| JP2019527537A5 (enExample) | ||
| JP2024023228A5 (enExample) | ||
| IL252617B (en) | All B-cell maturation antigen-directed chimeric antigen receptors and their uses | |
| JP2022542559A5 (enExample) | ||
| US12103970B2 (en) | CAR-T cells with humanized CD19 ScFv | |
| JP2022513372A5 (enExample) | ||
| EP3240805A1 (en) | Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20 | |
| JP2022527081A5 (enExample) | ||
| JP2024514974A5 (enExample) | ||
| WO2018045034A1 (en) | Chimeric antigen receptors having gitr intracellular domain as co-stimulatory domain | |
| JP2024504162A5 (enExample) | ||
| CA3233085A1 (en) | Composition of recombinant antigen binding molecules and method of making and using thereof | |
| CN114286691B (zh) | Cs1-抗体和抗cs1-car-t细胞 | |
| WO2020112529A1 (en) | Car-t cells having humanized cd19 scfv with mutation in cdr 1 region | |
| CN114685659B (zh) | Cd22特异性人源化抗体及利用其的嵌合抗原受体 | |
| JP2021529539A5 (enExample) | ||
| CN114075287B (zh) | 人源化bcma抗体和bcma-car-t细胞 |